Cytokinetics (CYTK) Q2 2026 Earnings

5MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.55
-2.07
-1.6
-1.12

Details

Expected EPS
-1.652286
Actual EPS
-1.67
Surprise EPS
-0.02
Surprise Percent
+1.07%

Description

Cytokinetics (CYTK) has reported earnings of -1.67 per share for Q2 2026.

0 Comments

Share your thoughts